Last reviewed · How we verify
Ergocalciferol Capsules
At a glance
| Generic name | Ergocalciferol Capsules |
|---|---|
| Also known as | Vitamin D, Vitamin D2 |
| Sponsor | University of Texas Southwestern Medical Center |
| Drug class | Provitamin D2 Compound [EPC] |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
- Nausea
- Anorexia
- Constipation
- Polyuria
- Polydipsia
- Nocturia
- Weakness
- Stiffness
- Vague aches
- Weight loss
- Anemia
- Mild acidosis
Serious adverse events
- Irreversible renal insufficiency
- Nephrocalcinosis
- Generalized vascular calcification
- Impairment of renal function
- Hypercalciuria
- Reversible azotemia
- Hypertension
- Widespread calcification of soft tissues
- Mental retardation
- Bone demineralization (osteoporosis)
Drug interactions
- mineral oil
- thiazide diuretics
Key clinical trials
- Immune Mechanisms of Vitamin D to Reduce Chronic Pain After Burn (PHASE2)
- Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' Disease (PHASE2)
- High-Dose vs Standard Ergocalciferol for Vitamin D Normalization in Aggressive Non-Hodgkin Lymphoma (NA)
- Vitamin D Homeostasis in Sarcoidosis (PHASE4)
- Vitamin D Deficiency in Adults Following a Major Burn Injury (PHASE4)
- Vitamin D Supplementation on Reported Rates of Taxane-Induced Neuropathy (PHASE2)
- Vitamin D to ENhance TraUma REcovery (PHASE2)
- The Effects of Vitamin D2 Supplement During Pregnancy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ergocalciferol Capsules CI brief — competitive landscape report
- Ergocalciferol Capsules updates RSS · CI watch RSS
- University of Texas Southwestern Medical Center portfolio CI